Short and Long Term Prognosis of Patients Admitted to the ED With Acute Heart Failure (CRF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03806972|
Recruitment Status : Completed
First Posted : January 16, 2019
Last Update Posted : October 13, 2021
Heart failure (HF) is the leading cause of hospitalization ,rehospitalization and mortality for adults over 65 years of age.
This study aimed to assess mortality, and hospitalization rates at 30 days and one year after dicharge of patients with heart failure (HF) with reduced ejection fraction (HFrEF) compared to HF with preserved ejection fraction (HFpEF).
|Condition or disease|
|Acute Heart Failure|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||1800 participants|
|Target Follow-Up Duration:||12 Months|
|Official Title:||Short and Long Term Prognosis of Patients Admitted to the Emergency Department With Acute Heart Failure|
|Actual Study Start Date :||June 1, 2009|
|Actual Primary Completion Date :||October 1, 2021|
|Actual Study Completion Date :||October 1, 2021|
- Death or readmission rates [ Time Frame: within 365 days after hospital discharge ]A composite outcome of Death or readmission within 365 days of hospital discharge
- Death or readmission rates [ Time Frame: within 30 days after hospital discharge ]A composite outcome of Death or readmission within 30 days of hospital discharge
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03806972
|Monastir, Tunisia, 5000|
|Principal Investigator:||Nouira Semir, Professor||university Hospital of Monastir|